333 related articles for article (PubMed ID: 17588565)
21. The effect of non-depolarizing neuromuscular blocking agents on the release of acetylcholine from the right atrium of the guinea pig.
Manabe N
Acta Med Okayama; 1997 Feb; 51(1):13-8. PubMed ID: 9057930
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological analysis of the novel mode of interaction between xanomeline and the M1 muscarinic acetylcholine receptor.
Christopoulos A; Parsons AM; El-Fakahany EE
J Pharmacol Exp Ther; 1999 Jun; 289(3):1220-8. PubMed ID: 10336509
[TBL] [Abstract][Full Text] [Related]
23. Structure-function studies of allosteric agonism at M2 muscarinic acetylcholine receptors.
May LT; Avlani VA; Langmead CJ; Herdon HJ; Wood MD; Sexton PM; Christopoulos A
Mol Pharmacol; 2007 Aug; 72(2):463-76. PubMed ID: 17525129
[TBL] [Abstract][Full Text] [Related]
24. Diphenidol-related diamines as novel muscarinic M4 receptor antagonists.
Varoli L; Andreani A; Burnelli S; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Bedini A; Fazio N; Spampinato S
Bioorg Med Chem Lett; 2008 May; 18(9):2972-6. PubMed ID: 18395442
[TBL] [Abstract][Full Text] [Related]
25. Structure:action relationships among some desacetoxy analogues of pancuronium and vecuronium in the anesthetized cat.
Bowman WC; Rodger IW; Houston J; Marshall RJ; McIndewar I
Anesthesiology; 1988 Jul; 69(1):57-62. PubMed ID: 2898902
[TBL] [Abstract][Full Text] [Related]
26. The allosteric interaction of otenzepad (AF-DX 116) at muscarinic M2 receptors in guinea pig atria.
Lanzafame A; Christopoulos A; Mitchelson F
Eur J Pharmacol; 2001 Mar; 416(3):235-44. PubMed ID: 11290374
[TBL] [Abstract][Full Text] [Related]
27. Binding of orthosteric ligands to the allosteric site of the M(2) muscarinic cholinergic receptor.
Redka DS; Pisterzi LF; Wells JW
Mol Pharmacol; 2008 Sep; 74(3):834-43. PubMed ID: 18552124
[TBL] [Abstract][Full Text] [Related]
28. Muscarinic allosteric modulation: M2/M3 subtype selectivity of gallamine is independent of G-protein coupling specificity.
Tränkle C; Kostenis E; Mohr K
Naunyn Schmiedebergs Arch Pharmacol; 2001 Aug; 364(2):172-8. PubMed ID: 11534857
[TBL] [Abstract][Full Text] [Related]
29. Vinburnine decelerates [3H]N-methylscopolamine binding to recombinant human muscarinic M1-M4 acetylcholine receptors.
Maksay G; Bíró T; Kiss B
Eur J Pharmacol; 2004 Jan; 483(2-3):229-32. PubMed ID: 14729111
[TBL] [Abstract][Full Text] [Related]
30. Lithocholylcholine, a bile acid/acetylcholine hybrid, is a muscarinic receptor antagonist.
Cheng K; Khurana S; Chen Y; Kennedy RH; Zimniak P; Raufman JP
J Pharmacol Exp Ther; 2002 Oct; 303(1):29-35. PubMed ID: 12235229
[TBL] [Abstract][Full Text] [Related]
31. Heterotropic cooperativity within and between protomers of an oligomeric M(2) muscarinic receptor.
Shivnaraine RV; Huang XP; Seidenberg M; Ellis J; Wells JW
Biochemistry; 2012 Jun; 51(22):4518-40. PubMed ID: 22551249
[TBL] [Abstract][Full Text] [Related]
32. First gallamine-tacrine hybrid: design and characterization at cholinesterases and the M2 muscarinic receptor.
Elsinghorst PW; Cieslik JS; Mohr K; Tränkle C; Gütschow M
J Med Chem; 2007 Nov; 50(23):5685-95. PubMed ID: 17944454
[TBL] [Abstract][Full Text] [Related]
33. Modes of allosteric interactions with free and [3H]N-methylscopolamine-occupied muscarinic M2 receptors as deduced from buffer-dependent potency shifts.
Schröter A; Tränkle C; Mohr K
Naunyn Schmiedebergs Arch Pharmacol; 2000 Dec; 362(6):512-9. PubMed ID: 11138843
[TBL] [Abstract][Full Text] [Related]
34. Use of acetylcholine mustard to study allosteric interactions at the M(2) muscarinic receptor.
Suga H; Figueroa KW; Ehlert FJ
J Pharmacol Exp Ther; 2008 Nov; 327(2):518-28. PubMed ID: 18682569
[TBL] [Abstract][Full Text] [Related]
35. Modulation by certain conserved aspartate residues of the allosteric interaction of gallamine at the m1 muscarinic receptor.
Lee NH; Hu J; el-Fakahany EE
J Pharmacol Exp Ther; 1992 Jul; 262(1):312-6. PubMed ID: 1625205
[TBL] [Abstract][Full Text] [Related]
36. [3H]N-methylscopolamine dissociation from muscarine receptors affected by low concentrations of allosteric modulators.
Christopoulos A; Mitchelson F
Eur J Pharmacol; 1995 Aug; 290(3):259-62. PubMed ID: 7589221
[TBL] [Abstract][Full Text] [Related]
37. Allosteric site in M2 acetylcholine receptors: evidence for a major conformational change upon binding of an orthosteric agonist instead of an antagonist.
Grossmüller M; Antony J; Tränkle C; Holzgrabe U; Mohr K
Naunyn Schmiedebergs Arch Pharmacol; 2006 Jan; 372(4):267-76. PubMed ID: 16362429
[TBL] [Abstract][Full Text] [Related]
38. Neuromuscular blocking action of vecuronium in the dog and its reversal by neostigmine.
Jones RS
Res Vet Sci; 1985 Mar; 38(2):193-6. PubMed ID: 2860709
[TBL] [Abstract][Full Text] [Related]
39. Effects of non-depolarizing neuromuscular blocking agents on norepinephrine release from human atrial tissue obtained during cardiac surgery.
Sato K; Windisch K; Matko I; Vizi ES
Br J Anaesth; 1999 Jun; 82(6):904-9. PubMed ID: 10562787
[TBL] [Abstract][Full Text] [Related]
40. Pancuronium and gallamine are antagonists for pre- and post-junctional muscarinic receptors in the guinea-pig lung.
Fryer AD; Maclagan J
Naunyn Schmiedebergs Arch Pharmacol; 1987 Apr; 335(4):367-71. PubMed ID: 3600815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
